英国牛津基因科技公司(简称OGT)(Oxford Gene Technology) 
牛津基因技术公司（Oxford Gene Technology,OGT）1995年，主要进行高通量的核酸分析工作。除了进行基因组研究外，还包括核酸杂交等的基础研究，如研究核酸单链结构对杂交过程中双链形成的影响。萨瑟恩的研究小组还改进了反义核酸试剂使其效果更加理想，开发新的基因剔除试剂从而在细胞内基因操作方面得到广泛应用。

Founded in 1995 by the pioneer of Southern Blotting and microarray technologies, Professor Sir Edwin Southern, OGT is based in Oxford, UK.
OGT's management team brings a unique combination of world-recognised science, combined with a strong track record in licensing intellectual property, product development and commercialisation of technology
Founded in 1995 by the pioneer of Southern Blotting, Professor Sir Edwin Southern, OGT operates out of Begbroke Business Park near Oxford, with excellent access to a growing network of life science companies
· OGT offers a comprehensive custom microarray consultancy service, from experimental design through all stages to data analysis and interpretation. It has a strong proven track record in providing custom microarray service in a range of applications, and in May 2006 announced the launch of its first microarray product, an Escherichia coli K12 ChIP on chip, the first ChIP microarray product to be launched as part of OGT’s Prokaryotic Chip2 family

The key focus areas of OGT include:

1. Array-based application products and services for life science research and molecular diagnostics. OGT’s flexible and cost-effective, customised DNA microarray service covers a range of applications, offering specialist support and assisting customers with every aspect of their research, from initial consultation and experimental design to probe selection, array design and fabrication through to data analysis and interpretation.

2. Development of innovative platform products for clinical research and diagnostics

3. Licensing. OGT operates an open licensing policy which has successfully provided access for a number of companies to OGT's fundamental intellectual property, particularly in the area of microarrays